Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7944 results

Sort By:

Tumescence in HNC Skin Graft Reconstruction

Study ID: NCT04967391
Start Date: 2021-09-01
End Date: 2025-08-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

58

Intervention / Treatment

Tumescence During STSG Harvest

Sponsor

University of California, Davis

Source: clinicaltrials.gov

Share:
Add to list

An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks

Study ID: NCT05617391
Start Date: 2022-12-13
End Date: 2026-06
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1300

Intervention / Treatment
Sponsor

St. Jude Children's Research Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer

Study ID: NCT06163391
Start Date: 2024-05-09
End Date: 2026-10
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

SOT201

Sponsor

Saidio biotech ag

Source: clinicaltrials.gov

Share:
Add to list

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

Study ID: NCT05902494
Start Date: 2023-06-29
End Date: 2025-07-14
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

350

Intervention / Treatment
Sponsor

Seagen, a wholly owned subsidiary of Pfizer

Source: clinicaltrials.gov

Share:
Add to list

FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

Study ID: NCT05304962
Start Date: 2022-03-04
End Date: 2026-09-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

64

Intervention / Treatment

RGT-419B

RGT-419B in combination with hormonal therapy

Sponsor

Regor Pharmaceuticals Inc.

Source: clinicaltrials.gov

Share:
Add to list

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer

Study ID: NCT05562791
Start Date: 2022-09-28
End Date: 2026-09
Study Type

Interventional

Study Phase

Phase1

No. of Participants

20

Intervention / Treatment

[68Ga]PSMA

PET/CT imaging

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

Study ID: NCT03550391
Start Date: 2018-11-22
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

206

Intervention / Treatment

Memantine

Hippocampal-avoidant (HA-WBRT) Radiotherapy

Stereotactic Radiosurgery (SRS)

Sponsor

Canadian Cancer Trials Group

Source: clinicaltrials.gov

Share:
Add to list

Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients

Study ID: NCT06263491
Start Date: 2024-05-29
End Date: 2027-03-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

Rituximab

Pester

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Trauma-Informed Procedural Pain Intervention: Refinement of an Evidence-Based Protocol

Study ID: NCT06705491
Start Date: 2025-01
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Tipp-r

Sponsor

University of Louisville

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Study ID: NCT05150691
Start Date: 2022-01-31
End Date: 2027-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

796

Intervention / Treatment

DB-1303/BNT323

Pertuzumab Injection

Ritonavir

Itraconazole

Sponsor

DualityBio Inc.

Source: clinicaltrials.gov

Share:
Add to list